Tuesday, November 30, 2010

Sneaky Drug Advertising: A Historical Perspective

›
Back in May, historians Jeremy A. Greene and David Herzberg published a paper reviewing drug advertising in the 20th century (subscription r...

Villains and Victims: Where Does Commentary Turn to Mudslinging?

›
Bruce Wilson of Montreal wrote an excellent comment on the recent post quoting Alastair Matheson: http://brodyhooked.blogspot.com/2010/11/ho...

Ghostwriting: From Journal Articles to Textbooks

›
Duff Wilson's piece in today's New York Times (disclaimer: I have a very small speaking part)-- http://www.nytimes.com/2010/11/30/b...
5 comments:
Sunday, November 28, 2010

How Pharma Shapes Knowledge: Alastair Matheson Responds

›
In hopes of soliciting a few words of helpful commentary, I shot an e-mail to Alastair Matheson, the author of the article in BioSocieties ...
2 comments:
Thursday, November 25, 2010

How Commerce Reshapes Knowledge: Matheson on Pharma's Influence on Science

›
I recently read David Egilman and Emily Ardolino's well-done, comprehensive chapter in The Bottom Line or Public Health: Tactics Corpora...
2 comments:
Tuesday, November 23, 2010

Massachusetts Payment Data Now Available

›
Coverage of the release of data under the new Massachusetts sunshine law on moneys paid by drug and device companies to physicians and other...
3 comments:
Monday, November 22, 2010

From Health Care Renewal: Drug CEO Suffers Consequences, Sort Of

›
Over on our friends Health Care Renewal blog appears this story: http://hcrenewal.blogspot.com/2010/11/former-kv-pharmaceutical-ceo-and.html...